The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies (Q40064149)

17 September 2017

The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies (English)

1 reference

17 September 2017

1 reference

Gast D

1

1 reference

17 September 2017

Riedle S

2

1 reference

17 September 2017

Issa Y

3

1 reference

17 September 2017

Pfeifer M

4

1 reference

17 September 2017

Beckhove P

5

1 reference

17 September 2017

Sanderson MP

6

1 reference

17 September 2017

Arlt M

7

1 reference

17 September 2017

Moldenhauer G

8

1 reference

17 September 2017

Fogel M

9

1 reference

17 September 2017

Krüger A

10

1 reference

17 September 2017

Altevogt P

11

1 reference

17 September 2017

language of work or name

English

0 references

publication date

22 October 2007

1 reference

17 September 2017

1 reference

17 September 2017

27

1 reference

17 September 2017

9

1 reference

17 September 2017

1281-1289

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210747

17 September 2017

0 references

cites work

Gene regulation in melanoma progression by the AP-2 transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

L1-mediated branching is regulated by two ezrin-radixin-moesin (ERM)-binding sites, the RSLE region and a novel juxtamembrane ERM-binding region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

RanBPM is an L1-interacting protein that regulates L1-mediated mitogen-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Chronic activation of ERK and neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Impaired neurite outgrowth of src-minus cerebellar neurons on the cell adhesion molecule L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

The adhesion molecule L1 (CD171) promotes melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Mitogen-activated protein kinases: specific messages from ubiquitous messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

L1 expressed by glioma cells promotes adhesion but not migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Ethanol inhibits L1 cell adhesion molecule activation of mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

7 January 2021

Sulfated glycosaminoglycans enhance tumor cell invasion in vitro by stimulating plasminogen activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

7 January 2021

L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

7 January 2021

ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

7 January 2021

Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

7 January 2021

Retinoids in cancer chemoprevention.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

7 January 2021

A MAP kinase-signaling pathway mediates neurite outgrowth on L1 and requires Src-dependent endocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

7 January 2021

The neural cell adhesion molecule L1 potentiates integrin-dependent cell migration to extracellular matrix proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

7 January 2021

Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210747

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210747

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference